Medicaid prescriptions · CMS State Drug Utilization Data · edition 2026-11
Medicaid prescriptions by state, drug by drug
Pick a drug and see how many Medicaid prescriptions and how much Medicaid reimbursement CMS publishes for each state and territory. Where managed-care figures are withheld the state is hatched, because its published total covers only part of Medicaid use. For the 775 drugs in this edition, 2024 publishes $58.58 billion across 52 states and territories, before manufacturer rebates.
Read this first. Figures are published reimbursement for the drugs in the OmniRx edition, not total Medicaid spending, and not a patient price. n/a means not published, which is not zero. Bigger states have bigger totals; use reimbursement per prescription to compare states fairly.
All drugs in this edition by state
Loading the data. $58.58 billion in Medicaid reimbursement for 2024 is published across the drugs in this edition; the tables below hold the main figures.
Swipe the map sideways to read it across
States ranked
No state has a value for this choice.
Select a state on the map or in the ranking to see its numbers and its top drugs.
Main figures (no JavaScript needed)
Top states by Medicaid reimbursement for the drugs in this edition, 2024, before rebates. 110,977,528 prescriptions are published in all.
State
Medicaid reimbursement
Prescriptions
Completeness
CA
$9,798,908,692
13,271,480
41% of rows are fee-for-service only
NY
$6,799,791,880
10,021,154
45% of rows are fee-for-service only
PA
$2,917,154,506
5,680,982
61% of rows are fee-for-service only
MI
$2,532,389,717
4,752,804
37% of rows are fee-for-service only
OH
$2,422,506,608
5,843,067
52% of rows are fee-for-service only
IL
$2,088,646,775
3,866,916
62% of rows are fee-for-service only
NC
$1,815,777,474
3,255,306
52% of rows are fee-for-service only
FL
$1,745,436,993
3,300,518
59% of rows are fee-for-service only
TX
$1,691,764,359
3,818,296
69% of rows are fee-for-service only
IN
$1,682,358,543
3,029,949
51% of rows are fee-for-service only
Top drugs by Medicaid reimbursement across all states, 2024.
Every figure is read from CMS State Drug Utilization Data, which reports Medicaid prescriptions and reimbursement by state and NDC. OmniRx groups NDCs under the FDA's drug name and sums them by state and year. The data file behind this page, with every cell and its completeness, is /data/medicaid-explorer.json. Edition 2026-11, Merkle root 006ab9a329709cbe. See the editions page and the licence page for the full dataset.
300 of 775 drugs are selectable here, covering 99.3% of the reimbursement published for them. 173 link to their OmniRx page.
Questions
What does the Medicaid by state explorer show?
For each drug in the OmniRx edition, how many Medicaid prescriptions and how much Medicaid reimbursement CMS State Drug Utilization Data publishes for each state and territory, year by year.
Why are some states hatched?
Where a state's managed-care figures are withheld, the published totals cover only fee-for-service use, so the true total is higher. A hatched state has half or more such rows for the drug; the tooltip and the state panel give the exact share.
Is reimbursement the real cost or a patient price?
No. It is the amount reimbursed before manufacturer rebates, so it is not Medicaid's net cost and not what a patient pays.
Does n/a mean zero?
No. n/a means the data is not published for that drug and state, or was suppressed. That is not the same as zero.
What does choosing an ingredient do?
It adds up every listed product that carries the same FDA generic name, for example Ozempic and Wegovy under semaglutide, so a brand and its generics are counted together. Products whose generic name is written differently are not merged. Completeness is weighted by the number of published rows, not averaged.
Why does the explorer not compare 2024 and 2025?
The two years have very different numbers of published rows in this edition, so a change between them can be a gap in publication and not a change in use.